Comparison of outpatient systemic antibacterial use in 2004 in the United States and 27 European countries
Comparison of outpatient systemic antibacterial use in 2004 in the United States and 27 European countries
复制标题
DOI：
10.1086/512810
复制
发表时间：
2007-04-15
影响因子：
11.8
通讯作者：
Stephens, Peter
中科院分区：
文献类型：
--
作者：
Goossens, Herman;Ferech, Matus;Stephens, Peter
欧洲抗菌药物消费监测（ESAC）项目收集欧洲抗菌药物使用数据，采用世界卫生组织推荐的解剖学治疗化学分类系统和限定日剂量方法。从IMS Health收集了美国的可比数据。根据ESAC方法处理的IMS Health销售数据表明，美国的门诊抗菌药物使用率很高（27个欧洲国家中只有3个国家使用更多），主要特征是转向新型抗生素。
The European Surveillance of Antimicrobial Consumption (ESAC) project collects data on antibacterial use in Europe, applying the Anatomic Therapeutic Chemical classification system and defined daily dose methodology, as recommended by the World Health Organization. Comparable data for the United States have been collected from IMS Health. The IMS Health sales data, processed according to ESAC methodology, suggest that outpatient antibacterial use in the United States is high (only 3 of 27 European countries used more) and is mainly characterized by a shift towards newer antibiotics.